Full Body Intelligence
At homeFrom $349 · Viome
Test at home for peace of mind
Provider-reviewed saliva screen for oral and throat cancer biomarkers using Viome's RNA platform
Viome CancerDetect - Oral & Throat is an at-home saliva test that screens for molecular features associated with oral squamous cell carcinoma and oropharyngeal squamous cell carcinoma. It uses Viome's RNA metatranscriptomic platform to analyze host gene expression and microbial activity in saliva, then runs the sample through Viome's CLIA-certified Bothell lab. The product has FDA Breakthrough Device designation and a built-in PWNHealth review before the kit ships and after lab analysis.
Every order is reviewed by a PWNHealth-licensed provider before the kit ships to assess clinical appropriateness. After lab analysis, a PWNHealth provider reviews the result. If molecular features are detected, the provider calls the patient to discuss the report and next steps.
CancerDetect uses saliva RNA patterns to return a Detected or Not Detected result for oral and throat cancer-associated molecular features. A PWNHealth provider reviews clinical appropriateness before shipping, then reviews the result after lab analysis. If molecular features are detected, the provider calls the patient to discuss the report and next steps.
CancerDetect does not include definitive diagnosis, treatment, prescriptions, ongoing medical care, HPV genotyping, biopsy, imaging, or coverage of cancers outside the oral cavity and oropharynx.
Performance claims on the product page: 90% sensitivity for OSCC, 90% sensitivity for OPSCC, 95% cancer-free specificity. The page frames these against a published meta-analysis of conventional oral examination (Essat et al. 2022) reporting 71% sensitivity (95% CI: 57%–81%) and 85% specificity (95% CI: 68%–94%) across 14 studies. Underlying validation: Banavar et al., Oral Oncology Vol. 145 (Oct 2023) and Banavar et al., NPJ Genomic Medicine 2021;6(1):105.
$599 covers one CancerDetect - Oral & Throat kit, saliva collection materials, prepaid USPS First-Class return mailer, lab analysis at the CLIA-certified Bothell lab, PWNHealth eligibility review before shipping, PWNHealth result review after analysis, digital PDF report, and provider phone consultation if molecular features are detected.
Full kit, lab processing, both pre-ship and post-analysis PWNHealth provider review, PDF report, and post-result provider consultation if Detected. Promo code DETECT takes $300 off ($299 effective).
None — at-home saliva collection, no phlebotomy.
Included. PWNHealth provider review of eligibility and results, and a post-result phone consultation when molecular features are detected, are bundled into the $599 price.
Prices checked 4 May 2026
Complete the eligibility questionnaire and place the order. A PWNHealth-licensed healthcare provider reviews the request for clinical appropriateness within 48 hours (up to 2 business days) before the kit ships. The order is not processed until that review clears.
Once the kit arrives, register it with the unique kit ID on cancerdetect.viome.com to link the sample to the patient account.
Collect the saliva sample at home using the included materials. No fasting, no diet or medication changes, minimum preparation. Use the prepaid First-Class USPS label and mailing envelope to ship the sample to Viome's CLIA-certified Bothell, WA lab.
Complete the CancerDetect — Oral & Throat health questionnaires on my.viome.com so the lab and PWNHealth provider have the medical context for analysis and review.
After lab analysis, a PWNHealth provider reviews the result and a printable PDF report is delivered through my.viome.com. If molecular features are detected, the same provider calls the patient to discuss results and next steps; if unreachable within 14 days, a hard copy is sent by certified mail.
$$ · From $399 · 50+ health scores across gut, oral, and cellular pathways · Viome
Stool, saliva, and blood RNA test with 50+ health scores, Biological Age, and personalized food guidance
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.